nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—BCHE—obesity	0.584	1	CbGaD
Succinylcholine—BCHE—diaphragm—obesity	0.0111	0.175	CbGeAlD
Succinylcholine—CHRM3—muscle of abdomen—obesity	0.0109	0.171	CbGeAlD
Succinylcholine—CHRNE—pituitary gland—obesity	0.00791	0.124	CbGeAlD
Succinylcholine—Pulmonary function test decreased—Phenylpropanolamine—obesity	0.00701	0.0436	CcSEcCtD
Succinylcholine—Respiratory depression—Phenylpropanolamine—obesity	0.00701	0.0436	CcSEcCtD
Succinylcholine—Decamethonium—HRH3—obesity	0.0052	0.724	CrCbGaD
Succinylcholine—Intraocular pressure increased—Sibutramine—obesity	0.00508	0.0316	CcSEcCtD
Succinylcholine—CHRND—respiratory system—obesity	0.00462	0.0726	CbGeAlD
Succinylcholine—Intraocular pressure increased—Bupropion—obesity	0.00443	0.0275	CcSEcCtD
Succinylcholine—Muscle contractions involuntary—Bupropion—obesity	0.00403	0.0251	CcSEcCtD
Succinylcholine—CHRNG—adipose tissue—obesity	0.00394	0.0618	CbGeAlD
Succinylcholine—Muscle rigidity—Bupropion—obesity	0.00381	0.0237	CcSEcCtD
Succinylcholine—CHRND—cardiovascular system—obesity	0.00354	0.0556	CbGeAlD
Succinylcholine—Cardiac arrest—Phentermine—obesity	0.00349	0.0217	CcSEcCtD
Succinylcholine—Ventricular fibrillation—Sibutramine—obesity	0.00292	0.0181	CcSEcCtD
Succinylcholine—Flushing—Phendimetrazine—obesity	0.00288	0.0179	CcSEcCtD
Succinylcholine—Intraocular pressure increased—Topiramate—obesity	0.00282	0.0175	CcSEcCtD
Succinylcholine—Apnoea—Sibutramine—obesity	0.00264	0.0164	CcSEcCtD
Succinylcholine—Muscle contractions involuntary—Topiramate—obesity	0.00257	0.016	CcSEcCtD
Succinylcholine—Flushing—Phenylpropanolamine—obesity	0.00246	0.0153	CcSEcCtD
Succinylcholine—Tachycardia—Methamphetamine—obesity	0.00245	0.0152	CcSEcCtD
Succinylcholine—Arrhythmia—Phenylpropanolamine—obesity	0.00237	0.0147	CcSEcCtD
Succinylcholine—Tachycardia—Benzphetamine—obesity	0.00236	0.0147	CcSEcCtD
Succinylcholine—Renal failure—Cimetidine—obesity	0.0023	0.0143	CcSEcCtD
Succinylcholine—Rhabdomyolysis—Bupropion—obesity	0.0022	0.0137	CcSEcCtD
Succinylcholine—Hyperkalaemia—Sibutramine—obesity	0.0022	0.0136	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Sibutramine—obesity	0.00217	0.0135	CcSEcCtD
Succinylcholine—Tachycardia—Phendimetrazine—obesity	0.00215	0.0134	CcSEcCtD
Succinylcholine—Bradycardia—Cimetidine—obesity	0.00214	0.0133	CcSEcCtD
Succinylcholine—CHRNA1—endocrine gland—obesity	0.00203	0.0318	CbGeAlD
Succinylcholine—CHRNB1—adipose tissue—obesity	0.00201	0.0316	CbGeAlD
Succinylcholine—Urticaria—Methamphetamine—obesity	0.00199	0.0124	CcSEcCtD
Succinylcholine—Decamethonium—BCHE—obesity	0.00198	0.276	CrCbGaD
Succinylcholine—Arrhythmia—Diethylpropion—obesity	0.00197	0.0123	CcSEcCtD
Succinylcholine—Hypertonia—Sibutramine—obesity	0.00196	0.0122	CcSEcCtD
Succinylcholine—Urticaria—Benzphetamine—obesity	0.00192	0.0119	CcSEcCtD
Succinylcholine—Hypertension—Phentermine—obesity	0.00191	0.0119	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Bupropion—obesity	0.00189	0.0118	CcSEcCtD
Succinylcholine—Hypersensitivity—Methamphetamine—obesity	0.00185	0.0115	CcSEcCtD
Succinylcholine—Tachycardia—Phenylpropanolamine—obesity	0.00184	0.0114	CcSEcCtD
Succinylcholine—CHRNB1—adrenal gland—obesity	0.0018	0.0283	CbGeAlD
Succinylcholine—Hypersensitivity—Benzphetamine—obesity	0.00178	0.0111	CcSEcCtD
Succinylcholine—Hypotension—Phenylpropanolamine—obesity	0.00176	0.0109	CcSEcCtD
Succinylcholine—Tachycardia—Phentermine—obesity	0.00176	0.0109	CcSEcCtD
Succinylcholine—Hypertonia—Bupropion—obesity	0.00171	0.0106	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Sibutramine—obesity	0.00168	0.0104	CcSEcCtD
Succinylcholine—Myalgia—Diethylpropion—obesity	0.00164	0.0102	CcSEcCtD
Succinylcholine—Myalgia—Cimetidine—obesity	0.00156	0.00968	CcSEcCtD
Succinylcholine—Cardiac arrest—Sibutramine—obesity	0.00154	0.00959	CcSEcCtD
Succinylcholine—Tachycardia—Diethylpropion—obesity	0.00153	0.00951	CcSEcCtD
Succinylcholine—Anaphylactic shock—Cimetidine—obesity	0.00149	0.00928	CcSEcCtD
Succinylcholine—CHRM2—cardiovascular system—obesity	0.00146	0.023	CbGeAlD
Succinylcholine—Tachycardia—Cimetidine—obesity	0.00146	0.00905	CcSEcCtD
Succinylcholine—Urticaria—Phentermine—obesity	0.00143	0.0089	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Diethylpropion—obesity	0.00143	0.00888	CcSEcCtD
Succinylcholine—Bronchospasm—Orlistat—obesity	0.00142	0.00886	CcSEcCtD
Succinylcholine—CHRNB1—liver—obesity	0.00141	0.0222	CbGeAlD
Succinylcholine—Hypersensitivity—Phenylpropanolamine—obesity	0.00139	0.00863	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Cimetidine—obesity	0.00136	0.00845	CcSEcCtD
Succinylcholine—CHRM1—cardiovascular system—obesity	0.00133	0.0209	CbGeAlD
Succinylcholine—Renal failure—Orlistat—obesity	0.00127	0.00789	CcSEcCtD
Succinylcholine—BCHE—respiratory system—obesity	0.00127	0.0199	CbGeAlD
Succinylcholine—Urticaria—Diethylpropion—obesity	0.00125	0.00774	CcSEcCtD
Succinylcholine—Renal failure—Sibutramine—obesity	0.00123	0.00764	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Topiramate—obesity	0.00121	0.00749	CcSEcCtD
Succinylcholine—Bronchospasm—Bupropion—obesity	0.0012	0.00747	CcSEcCtD
Succinylcholine—Rash—Phenylpropanolamine—obesity	0.00119	0.00738	CcSEcCtD
Succinylcholine—Dermatitis—Phenylpropanolamine—obesity	0.00119	0.00738	CcSEcCtD
Succinylcholine—Body temperature increased—Cimetidine—obesity	0.00118	0.00733	CcSEcCtD
Succinylcholine—Bradycardia—Sibutramine—obesity	0.00114	0.0071	CcSEcCtD
Succinylcholine—Rash—Phentermine—obesity	0.00114	0.00707	CcSEcCtD
Succinylcholine—Dermatitis—Phentermine—obesity	0.00114	0.00706	CcSEcCtD
Succinylcholine—Hypersensitivity—Cimetidine—obesity	0.0011	0.00683	CcSEcCtD
Succinylcholine—Hypertonia—Topiramate—obesity	0.00109	0.00676	CcSEcCtD
Succinylcholine—CHRM3—adipose tissue—obesity	0.00105	0.0165	CbGeAlD
Succinylcholine—CHRM2—endocrine gland—obesity	0.001	0.0158	CbGeAlD
Succinylcholine—Arrhythmia—Sibutramine—obesity	0.001	0.00623	CcSEcCtD
Succinylcholine—CHRM3—digestive system—obesity	0.000989	0.0155	CbGeAlD
Succinylcholine—Rash—Diethylpropion—obesity	0.000989	0.00615	CcSEcCtD
Succinylcholine—Dermatitis—Diethylpropion—obesity	0.000988	0.00614	CcSEcCtD
Succinylcholine—BCHE—cardiovascular system—obesity	0.000972	0.0153	CbGeAlD
Succinylcholine—Rash—Cimetidine—obesity	0.000941	0.00585	CcSEcCtD
Succinylcholine—Dermatitis—Cimetidine—obesity	0.00094	0.00584	CcSEcCtD
Succinylcholine—CHRM1—endocrine gland—obesity	0.000913	0.0143	CbGeAlD
Succinylcholine—Flushing—Bupropion—obesity	0.000908	0.00564	CcSEcCtD
Succinylcholine—Arrhythmia—Bupropion—obesity	0.000874	0.00543	CcSEcCtD
Succinylcholine—BCHE—pituitary gland—obesity	0.000861	0.0135	CbGeAlD
Succinylcholine—Myalgia—Orlistat—obesity	0.000859	0.00534	CcSEcCtD
Succinylcholine—BCHE—adipose tissue—obesity	0.000857	0.0135	CbGeAlD
Succinylcholine—Hypertension—Sibutramine—obesity	0.000843	0.00524	CcSEcCtD
Succinylcholine—Myalgia—Sibutramine—obesity	0.000832	0.00517	CcSEcCtD
Succinylcholine—Anaphylactic shock—Orlistat—obesity	0.000824	0.00512	CcSEcCtD
Succinylcholine—CHRM3—endocrine gland—obesity	0.000817	0.0128	CbGeAlD
Succinylcholine—BCHE—digestive system—obesity	0.000807	0.0127	CbGeAlD
Succinylcholine—Anaphylactic shock—Sibutramine—obesity	0.000797	0.00496	CcSEcCtD
Succinylcholine—Shock—Sibutramine—obesity	0.000784	0.00488	CcSEcCtD
Succinylcholine—Tachycardia—Sibutramine—obesity	0.000778	0.00484	CcSEcCtD
Succinylcholine—BCHE—adrenal gland—obesity	0.000769	0.0121	CbGeAlD
Succinylcholine—Musculoskeletal discomfort—Orlistat—obesity	0.000751	0.00467	CcSEcCtD
Succinylcholine—Hypotension—Sibutramine—obesity	0.000745	0.00463	CcSEcCtD
Succinylcholine—Hypertension—Bupropion—obesity	0.000735	0.00457	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Sibutramine—obesity	0.000726	0.00452	CcSEcCtD
Succinylcholine—Myalgia—Bupropion—obesity	0.000725	0.00451	CcSEcCtD
Succinylcholine—Anaphylactic shock—Bupropion—obesity	0.000695	0.00432	CcSEcCtD
Succinylcholine—Shock—Bupropion—obesity	0.000684	0.00425	CcSEcCtD
Succinylcholine—Renal failure—Topiramate—obesity	0.000683	0.00424	CcSEcCtD
Succinylcholine—Tachycardia—Bupropion—obesity	0.000678	0.00422	CcSEcCtD
Succinylcholine—BCHE—endocrine gland—obesity	0.000667	0.0105	CbGeAlD
Succinylcholine—Urticaria—Orlistat—obesity	0.000654	0.00407	CcSEcCtD
Succinylcholine—Body temperature increased—Orlistat—obesity	0.000651	0.00405	CcSEcCtD
Succinylcholine—Hypotension—Bupropion—obesity	0.000649	0.00404	CcSEcCtD
Succinylcholine—Bradycardia—Topiramate—obesity	0.000635	0.00394	CcSEcCtD
Succinylcholine—Urticaria—Sibutramine—obesity	0.000633	0.00394	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Bupropion—obesity	0.000633	0.00394	CcSEcCtD
Succinylcholine—Body temperature increased—Sibutramine—obesity	0.00063	0.00392	CcSEcCtD
Succinylcholine—Hypersensitivity—Orlistat—obesity	0.000607	0.00377	CcSEcCtD
Succinylcholine—BCHE—liver—obesity	0.000601	0.00944	CbGeAlD
Succinylcholine—Hypersensitivity—Sibutramine—obesity	0.000587	0.00365	CcSEcCtD
Succinylcholine—Flushing—Topiramate—obesity	0.000578	0.0036	CcSEcCtD
Succinylcholine—Urticaria—Bupropion—obesity	0.000552	0.00343	CcSEcCtD
Succinylcholine—Body temperature increased—Bupropion—obesity	0.000549	0.00342	CcSEcCtD
Succinylcholine—Rash—Orlistat—obesity	0.000519	0.00323	CcSEcCtD
Succinylcholine—Dermatitis—Orlistat—obesity	0.000519	0.00323	CcSEcCtD
Succinylcholine—Hypersensitivity—Bupropion—obesity	0.000512	0.00318	CcSEcCtD
Succinylcholine—Rash—Sibutramine—obesity	0.000503	0.00312	CcSEcCtD
Succinylcholine—Dermatitis—Sibutramine—obesity	0.000502	0.00312	CcSEcCtD
Succinylcholine—Hypertension—Topiramate—obesity	0.000468	0.00291	CcSEcCtD
Succinylcholine—Myalgia—Topiramate—obesity	0.000462	0.00287	CcSEcCtD
Succinylcholine—Rash—Bupropion—obesity	0.000438	0.00272	CcSEcCtD
Succinylcholine—Dermatitis—Bupropion—obesity	0.000438	0.00272	CcSEcCtD
Succinylcholine—Shock—Topiramate—obesity	0.000436	0.00271	CcSEcCtD
Succinylcholine—Tachycardia—Topiramate—obesity	0.000432	0.00269	CcSEcCtD
Succinylcholine—Hypotension—Topiramate—obesity	0.000414	0.00257	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Topiramate—obesity	0.000403	0.00251	CcSEcCtD
Succinylcholine—Urticaria—Topiramate—obesity	0.000352	0.00219	CcSEcCtD
Succinylcholine—Body temperature increased—Topiramate—obesity	0.00035	0.00218	CcSEcCtD
Succinylcholine—Hypersensitivity—Topiramate—obesity	0.000326	0.00203	CcSEcCtD
Succinylcholine—Rash—Topiramate—obesity	0.000279	0.00174	CcSEcCtD
Succinylcholine—Dermatitis—Topiramate—obesity	0.000279	0.00173	CcSEcCtD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CG—obesity	1.3e-05	7.06e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GNAS—obesity	1.3e-05	7.05e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GCG—obesity	1.3e-05	7.05e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PTPN1—obesity	1.3e-05	7.05e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AKT2—obesity	1.3e-05	7.05e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—DRD2—obesity	1.29e-05	7.03e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GCG—obesity	1.29e-05	7.03e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PTPN1—obesity	1.29e-05	7.03e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CG—obesity	1.29e-05	6.99e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PTPN1—obesity	1.28e-05	6.96e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GCG—obesity	1.28e-05	6.96e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—APOB—obesity	1.27e-05	6.91e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CD—obesity	1.26e-05	6.86e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CD—obesity	1.26e-05	6.84e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.25e-05	6.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CD—obesity	1.25e-05	6.77e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—POMC—obesity	1.24e-05	6.74e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PRL—obesity	1.24e-05	6.73e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—POMC—obesity	1.24e-05	6.72e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PRL—obesity	1.23e-05	6.71e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—POMC—obesity	1.23e-05	6.66e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PRL—obesity	1.22e-05	6.64e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—STK11—obesity	1.22e-05	6.63e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—STK11—obesity	1.22e-05	6.61e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCL2—obesity	1.22e-05	6.6e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—LPL—obesity	1.21e-05	6.6e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCL2—obesity	1.21e-05	6.58e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PLG—obesity	1.21e-05	6.56e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—RHOA—obesity	1.21e-05	6.54e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—STK11—obesity	1.21e-05	6.54e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PLG—obesity	1.2e-05	6.53e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—RHOA—obesity	1.2e-05	6.52e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCL2—obesity	1.2e-05	6.51e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CG—obesity	1.19e-05	6.49e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AKT2—obesity	1.19e-05	6.48e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3R1—obesity	1.19e-05	6.48e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PLG—obesity	1.19e-05	6.47e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AKT2—obesity	1.19e-05	6.46e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—RHOA—obesity	1.19e-05	6.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3R1—obesity	1.19e-05	6.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GPX1—obesity	1.19e-05	6.44e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AKT2—obesity	1.18e-05	6.4e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FOXO3—obesity	1.18e-05	6.4e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3R1—obesity	1.18e-05	6.39e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ADRB2—obesity	1.18e-05	6.38e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FOXO3—obesity	1.17e-05	6.38e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ADRB2—obesity	1.17e-05	6.36e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FOXO3—obesity	1.16e-05	6.32e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ADRB2—obesity	1.16e-05	6.3e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SOCS1—obesity	1.16e-05	6.28e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CD36—obesity	1.15e-05	6.27e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SOCS1—obesity	1.15e-05	6.26e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PPARG—obesity	1.15e-05	6.26e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CD—obesity	1.15e-05	6.23e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CD—obesity	1.14e-05	6.21e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SOCS3—obesity	1.14e-05	6.21e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SOCS1—obesity	1.14e-05	6.2e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SOCS3—obesity	1.14e-05	6.19e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—POMC—obesity	1.14e-05	6.18e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CD—obesity	1.13e-05	6.15e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—INS—obesity	1.13e-05	6.14e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SOCS3—obesity	1.13e-05	6.13e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GNB3—obesity	1.12e-05	6.08e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GNB3—obesity	1.12e-05	6.06e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GNB3—obesity	1.1e-05	6e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—TYK2—obesity	1.1e-05	5.99e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CB—obesity	1.1e-05	5.98e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—TYK2—obesity	1.1e-05	5.97e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF2—obesity	1.1e-05	5.97e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CB—obesity	1.1e-05	5.96e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF2—obesity	1.1e-05	5.95e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—RHOA—obesity	1.09e-05	5.94e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—MTHFR—obesity	1.09e-05	5.94e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—RHOA—obesity	1.09e-05	5.92e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GNAS—obesity	1.09e-05	5.92e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—TYK2—obesity	1.09e-05	5.92e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CB—obesity	1.09e-05	5.9e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GNAS—obesity	1.09e-05	5.9e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF2—obesity	1.09e-05	5.89e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3R1—obesity	1.08e-05	5.88e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—RHOA—obesity	1.08e-05	5.87e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3R1—obesity	1.08e-05	5.86e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GNAS—obesity	1.08e-05	5.84e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PPARA—obesity	1.07e-05	5.83e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3R1—obesity	1.07e-05	5.81e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOB—obesity	1.07e-05	5.79e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOB—obesity	1.06e-05	5.78e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOB—obesity	1.05e-05	5.72e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CD—obesity	1.05e-05	5.7e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCL5—obesity	1.04e-05	5.66e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AGT—obesity	1.04e-05	5.64e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCL5—obesity	1.04e-05	5.64e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ALB—obesity	1.04e-05	5.63e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCL5—obesity	1.03e-05	5.59e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LPL—obesity	1.02e-05	5.53e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—APOE—obesity	1.02e-05	5.53e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LPL—obesity	1.02e-05	5.52e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FOXO1—obesity	1.01e-05	5.49e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—RPS6KB1—obesity	1.01e-05	5.48e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CAV1—obesity	1.01e-05	5.48e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FOXO1—obesity	1.01e-05	5.48e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—RPS6KB1—obesity	1.01e-05	5.47e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—APOA1—obesity	1.01e-05	5.47e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LPL—obesity	1.01e-05	5.46e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CB—obesity	1e-05	5.43e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FOXO1—obesity	9.99e-06	5.42e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—RPS6KB1—obesity	9.97e-06	5.41e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CB—obesity	9.97e-06	5.41e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—NOS3—obesity	9.92e-06	5.39e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3R1—obesity	9.92e-06	5.39e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CB—obesity	9.87e-06	5.36e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PRKCD—obesity	9.39e-06	5.1e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PRKCD—obesity	9.36e-06	5.08e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PRKCD—obesity	9.27e-06	5.03e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CG—obesity	9.19e-06	4.99e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HTR2A—obesity	9.19e-06	4.99e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—C3—obesity	9.17e-06	4.98e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HTR2A—obesity	9.16e-06	4.97e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CB—obesity	9.16e-06	4.97e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—C3—obesity	9.14e-06	4.97e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTGS2—obesity	9.07e-06	4.93e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HTR2A—obesity	9.07e-06	4.92e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—C3—obesity	9.06e-06	4.92e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PPARG—obesity	8.87e-06	4.82e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—POMC—obesity	8.75e-06	4.75e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IRS2—obesity	8.73e-06	4.74e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AGT—obesity	8.72e-06	4.73e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IRS2—obesity	8.7e-06	4.72e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—INS—obesity	8.7e-06	4.72e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AGT—obesity	8.69e-06	4.72e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IRS2—obesity	8.62e-06	4.68e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AGT—obesity	8.6e-06	4.67e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOE—obesity	8.54e-06	4.64e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LEP—obesity	8.54e-06	4.64e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LEP—obesity	8.51e-06	4.62e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOE—obesity	8.51e-06	4.62e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CAV1—obesity	8.46e-06	4.6e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOA1—obesity	8.44e-06	4.58e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CAV1—obesity	8.44e-06	4.58e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LEP—obesity	8.43e-06	4.58e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOE—obesity	8.43e-06	4.58e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOA1—obesity	8.42e-06	4.57e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CAV1—obesity	8.35e-06	4.54e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOA1—obesity	8.33e-06	4.53e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ESR1—obesity	8.15e-06	4.43e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ESR1—obesity	8.13e-06	4.41e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CD—obesity	8.08e-06	4.39e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—F2—obesity	8.05e-06	4.37e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PRKCB—obesity	8.05e-06	4.37e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ESR1—obesity	8.05e-06	4.37e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PRKCB—obesity	8.03e-06	4.36e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—F2—obesity	8.03e-06	4.36e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ALB—obesity	7.97e-06	4.33e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—BAD—obesity	7.96e-06	4.32e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—F2—obesity	7.95e-06	4.32e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PRKCB—obesity	7.95e-06	4.32e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—BAD—obesity	7.93e-06	4.31e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—BAD—obesity	7.86e-06	4.27e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CG—obesity	7.71e-06	4.19e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CG—obesity	7.68e-06	4.17e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3R1—obesity	7.63e-06	4.14e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—NOS3—obesity	7.63e-06	4.14e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IRS1—obesity	7.62e-06	4.14e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CG—obesity	7.61e-06	4.13e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IRS1—obesity	7.59e-06	4.12e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IRS1—obesity	7.52e-06	4.08e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—POMC—obesity	7.34e-06	3.98e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—POMC—obesity	7.31e-06	3.97e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—INS—obesity	7.3e-06	3.96e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—INS—obesity	7.27e-06	3.95e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—POMC—obesity	7.24e-06	3.93e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—INS—obesity	7.2e-06	3.91e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCL2—obesity	7.18e-06	3.9e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCL2—obesity	7.16e-06	3.89e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCL2—obesity	7.09e-06	3.85e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF1—obesity	7.06e-06	3.83e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT2—obesity	7.05e-06	3.83e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CB—obesity	7.04e-06	3.82e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF1—obesity	7.04e-06	3.82e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT2—obesity	7.03e-06	3.82e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTGS2—obesity	6.98e-06	3.79e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF1—obesity	6.97e-06	3.78e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT2—obesity	6.96e-06	3.78e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CD—obesity	6.78e-06	3.68e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CD—obesity	6.75e-06	3.67e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CA—obesity	6.71e-06	3.64e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SERPINE1—obesity	6.7e-06	3.64e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CA—obesity	6.69e-06	3.63e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CD—obesity	6.69e-06	3.63e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SERPINE1—obesity	6.68e-06	3.63e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CA—obesity	6.63e-06	3.6e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SERPINE1—obesity	6.62e-06	3.59e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TYK2—obesity	6.52e-06	3.54e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TYK2—obesity	6.5e-06	3.53e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—RHOA—obesity	6.47e-06	3.51e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—RHOA—obesity	6.44e-06	3.5e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TYK2—obesity	6.43e-06	3.49e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3R1—obesity	6.4e-06	3.47e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NOS3—obesity	6.4e-06	3.47e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—RHOA—obesity	6.38e-06	3.47e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3R1—obesity	6.38e-06	3.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NOS3—obesity	6.38e-06	3.46e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3R1—obesity	6.32e-06	3.43e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NOS3—obesity	6.32e-06	3.43e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CA—obesity	6.09e-06	3.31e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CA—obesity	6.08e-06	3.3e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CA—obesity	6.02e-06	3.27e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CB—obesity	5.91e-06	3.21e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MTOR—obesity	5.91e-06	3.21e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CB—obesity	5.89e-06	3.2e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MTOR—obesity	5.89e-06	3.2e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CB—obesity	5.83e-06	3.17e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MTOR—obesity	5.83e-06	3.17e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CA—obesity	5.58e-06	3.03e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AKT1—obesity	5.48e-06	2.98e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AKT1—obesity	5.47e-06	2.97e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AKT1—obesity	5.41e-06	2.94e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL6—obesity	5.4e-06	2.93e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL6—obesity	5.38e-06	2.92e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL6—obesity	5.33e-06	2.89e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MMP9—obesity	5.13e-06	2.79e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MMP9—obesity	5.12e-06	2.78e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MMP9—obesity	5.07e-06	2.75e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAPK8—obesity	4.99e-06	2.71e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AKT1—obesity	4.98e-06	2.7e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAPK8—obesity	4.98e-06	2.7e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AKT1—obesity	4.96e-06	2.7e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAPK8—obesity	4.93e-06	2.68e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AKT1—obesity	4.92e-06	2.67e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—STAT3—obesity	4.56e-06	2.48e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AKT1—obesity	4.56e-06	2.48e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—STAT3—obesity	4.55e-06	2.47e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—STAT3—obesity	4.51e-06	2.45e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CA—obesity	4.29e-06	2.33e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MYC—obesity	4.24e-06	2.3e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TGFB1—obesity	4.23e-06	2.3e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MYC—obesity	4.23e-06	2.3e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TGFB1—obesity	4.22e-06	2.29e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MYC—obesity	4.19e-06	2.27e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TGFB1—obesity	4.18e-06	2.27e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CA—obesity	3.6e-06	1.96e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CA—obesity	3.59e-06	1.95e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CA—obesity	3.55e-06	1.93e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AKT1—obesity	3.51e-06	1.9e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6—obesity	3.19e-06	1.73e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6—obesity	3.18e-06	1.73e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6—obesity	3.15e-06	1.71e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT1—obesity	2.94e-06	1.6e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT1—obesity	2.93e-06	1.59e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT1—obesity	2.9e-06	1.58e-05	CbGpPWpGaD
